10.6084/M9.FIGSHARE.21303584.V1
Ming Yi
Ming
Yi
Zhejiang University
Huazhong University of Science and Technology
Mengke Niu
Mengke
Niu
Huazhong University of Science and Technology
Yuze Wu
Yuze
Wu
Huazhong University of Science and Technology
Hong Ge
Hong
Ge
Henan Cancer Hospital
Dechao Jiao
Dechao
Jiao
First Affiliated Hospital of Zhengzhou University
Shuangli Zhu
Shuangli
Zhu
Huazhong University of Science and Technology
Jing Zhang
Jing
Zhang
Wuhan YZY Biopharma (China)
Yongxiang Yan
Yongxiang
Yan
Wuhan YZY Biopharma (China)
Pengfei Zhou
Pengfei
Zhou
Wuhan YZY Biopharma (China)
Qian Chu
Qian
Chu
Huazhong University of Science and Technology
Kongming Wu
Kongming
Wu
Huazhong University of Science and Technology
First Affiliated Hospital of Zhengzhou University
Additional file 7 of Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Additional file 7. Figure S7: The FACS gating strategies for the B16 model.
Immunology
figshare
2022
2022-10-10
2024-02-19
Figure
365026 Bytes
10.6084/m9.figshare.21303584
10.1016/j.immuni.2013.07.012
10.1084/jem.20112741
10.1016/j.cell.2018.09.035
10.1186/s13045-019-0779-5
10.1186/s40364-020-00212-5
10.1186/s40164-021-00211-8
10.1038/nature21349
10.1186/s12943-019-1091-2
10.1186/s40164-019-0143-z
10.1016/j.immuni.2019.12.011
10.1158/1078-0432.CCR-15-1507
10.1038/s41467-018-07767-w
10.1038/s41467-018-04724-5
10.1186/s40164-022-00277-y
10.1186/s40164-020-00165-3
10.2147/OTT.S224013
10.1186/s13045-021-01053-x
10.1186/s12943-021-01428-1
10.1038/nature25501
10.1038/nature25492
10.1186/s13045-021-01164-5
10.1186/s13045-021-01045-x
10.1186/s13045-021-01155-6
10.1038/nrclinonc.2015.209
10.1186/s40425-019-0573-5
10.1038/s41422-020-00395-4
10.1038/s41423-021-00669-w
10.1186/s13045-019-0721-x
10.1186/s13045-020-00916-z
10.1126/science.aba6098
10.1046/j.1523-1747.2000.00084.x
10.1006/meth.1999.0813
10.1038/s41590-018-0276-y
10.1016/j.cell.2020.11.009
10.1016/j.cell.2020.03.048
10.1136/jitc-2021-002809
10.1038/s41586-018-0130-2
10.1016/j.immuni.2020.05.001
10.1093/nar/gks461
10.1089/omi.2011.0118
10.1186/s40425-018-0356-4
10.1080/2162402X.2020.1824631
10.4049/jimmunol.1701675
10.4049/jimmunol.1400534
10.1016/j.trecan.2018.09.001
10.1093/annonc/mdw217
10.1186/s12943-022-01657-y
10.1186/s13045-021-01218-8
10.1186/s12943-021-01489-2
10.1016/j.it.2016.09.006
10.1186/s40164-021-00252-z
10.1038/s41577-019-0127-6
10.1016/j.ccell.2016.06.003
10.1158/2159-8290.CD-19-0761
10.1186/s12943-020-01247-w
10.1186/s13045-021-01085-3
10.1172/JCI86892
10.1158/2159-8290.CD-20-0812
10.1158/1078-0432.CCR-17-2653
10.1016/j.jtho.2020.03.003
10.1186/s13045-022-01363-8
CC BY + CC0